A new NIH-funded study reveals crucial protein changes in spinal fluid that may provide the first specific biomarkers for frontotemporal dementia (FTD), paving the way for earlier diagnosis and treatment options.
Breakingon.com is an independent news platform that delivers the latest news, trends, and analyses quickly and objectively. We gather and present the most important developments from around the world and local sources with accuracy and reliability. Our goal is to provide our readers with factual, unbiased, and comprehensive news content, making information easily accessible.
Stay informed with us!
